MedTrace Logo

Evaluation of an Integrated Economic Strengthening and HIV Prevention Program for Vulnerable Youth in South Africa

NCT02888678 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1773

Last updated 2018-06-18

No results posted yet for this study

Summary

This study evaluates whether the integration of an Economic Strengthening program with an HIV-prevention education program produce synergistic effects on economic and health outcomes for South African youth ages 14-17 years old.

Conditions

  • HIV
  • HIV Infections

Interventions

BEHAVIORAL

Economic Strengthening (Impumelelo)

Economic Strengthening (Impumelelo): This intervention consists of 15 one-hour long sessions on financial education in combination with access to appropriate youth-friendly savings mechanisms.

BEHAVIORAL

HIV Prevention Education (Vhutshilo 2.2)

HIV Prevention Education (Vhutshilo 2.2): This intervention consists of 15 one-hour long sessions that are interactive, skills focused, and cover such topics as expressing one's feelings; dealing with loss and grief; decision-making; coping; gender violence; understanding HIV and other sexually transmitted infections; healthy relationships and staying safe in sexual relationships; and contraception and risks associated with unplanned pregnancy.

Sponsors & Collaborators

  • Foundation for Professional Development

    collaborator UNKNOWN

  • Future Families

    collaborator UNKNOWN

  • FHI 360

    lead OTHER

Principal Investigators

  • Holly Burke, PhD · FHI 360

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
FACTORIAL

Eligibility

Min Age
14 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-02-29
Primary Completion
2018-05-31
Completion
2018-05-31

Countries

  • South Africa

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02888678 on ClinicalTrials.gov